Tatjana Weidinger-Traub
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications
Longitudinal serum uric acid levels are not associated with dopamine transporter binding in progressive supranuclear palsy.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: December 29, 2025
Preoperative prediction of 5-ALA fluorescence in gliomas: comparison of 7-Tesla magnetic resonance spectroscopic imaging, contrast-enhancement on MRI, and positron emission tomography.
Journal: European radiology
Published: October 15, 2025
From Compassionate Use Toward High-Level Evidence for Radiopharmaceutical Therapy in Recurrent Meningioma: The LUMEN-1 and MOMENTUM-1 Trials.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 11, 2025
Glutamine Metabolism and Metabolic Profiling Using 7 T CRT-FID MRSI in Focal Epilepsy.
Journal: European journal of neurology
Published: April 21, 2025
Use of 177Lu prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer : Joint statement of the Austrian Society of Nuclear Medicine and Theranostics and the Austrian Society of Urology and Andrology.
Journal: Wiener klinische Wochenschrift
Published: April 17, 2025
Lecanemab approval in EU: what should we be ready for?- the EANM perspective.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 09, 2025
Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.
Journal: Neuro-oncology
Published: November 18, 2024
Results from a phase I study of 4-l-[131I]iodo-phenylalanine ([131I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1).
Journal: Neuro-oncology advances
Published: August 30, 2024
Correction to: EANM perspectives for CZT SPECT in brain applications.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 17, 2024
Neuroimaging biomarkers in the biological definition of Parkinson's disease and dementia with Lewy bodies - EANM position on current state, unmet needs and future perspectives.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 22, 2024
Aβ status assessment in a hypothetical scenario prior to treatment with disease-modifying therapies: Evidence from 10-year real-world experience at university memory clinics.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: June 18, 2024
EANM perspectives for CZT SPECT in brain applications.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 10, 2024
Last Updated: 09/26/2026